Metagenomics Market

Global Metagenomics Market Size (2023 to 2028)

The global market size for metagenomics is estimated to be growing at a CAGR of 13.11% from 2023 to 2028 and be worth USD 1669 million by 2028 from USD 901.4 million in 2023.

Metagenomics is a field of study that uses sequencing and bioinformatics methods to learn more about the diversity of microbes in a community and how they interact. Metagenomic technologies have improved our understanding of microbial ecology and the role of microbiology in global geochemical cycles due to functional metagenomics. Furthermore, metagenomic research has allowed researchers to tap into a vast microbial diversity previously untapped by traditional microbiology methods.

Impact of COVID-19 on the global metagenomics market:

COVID-19 is a newly discovered coronavirus that causes an infectious disease. Following the World Health Organization's (WHO) declaration of the COVID-19 outbreak as a pandemic, a diverse group of established pharmaceutical and biopharmaceutical companies, as well as major players and smaller start-ups in the metagenomic sequencing market, have stepped forward to contribute to the global research efforts by developing test kits, treatments, and vaccines to combat the infection caused by the novel coronavirus. The genomes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of COVID-19, can now be sequenced within hours or days of a patient being diagnosed due to recent improvements in sequencing. The discovery and characterization of the novel pathogen required metagenomic sequencing. The use of metagenomics in investigating the connections between the microbiome and various pathological therapies related to COVID-19 infection is becoming more common. Metagenomic next-generation sequencing (mNGS) is one of the most advanced techniques for detecting SARS-CoV-2 from nasopharyngeal (NP) swabs. It also provides information on the composition of the upper respiratory tract microbiome. It aids in analyzing its relationship to coinfections or the presence of other organisms that may affect SARS-CoV-2 disease progression and prognosis.

MARKET DRIVERS:

Continuous technological innovations in NGS platforms, increasing initiatives and funding from government and private bodies for large-scale sequencing projects, declining genome sequencing costs, and significant metagenomics applications in various fields are primarily driving growth in the metagenomics market.

The market participants get an immediate competitive advantage when such products and technologies are introduced; as a result, significant corporations are increasingly focused on R&D to increase their market positions and share. In addition, one of the other primary factors driving the growth of the metagenomics market is the rising frequency of genetic disorders around the world.

Because DNA sequencing is so closely linked to metagenomics, technological advancements in DNA sequencing result in several advantages over traditional methods. During the forecast period, advances in DNA sequencing are projected to boost the market for metagenomics. Furthermore, increased worries about viral disorders such as virus-induced diarrhea, influenza, hepatitis B, HIV/AIDS, and an increasing number of genes being discovered have prompted the development of novel metagenome study products. During the forecast period, the global metagenomics market is expected to benefit from rapid growth in the life sciences industry, an increase in the number of clinical and diagnostics laboratories, and an increase in the use of metagenomics studies in genomics and proteomics.

MARKET RESTRAINTS:

Because metagenomics is a relatively new concept that entails analyzing and interpreting interactions in the microbial community, a lack of awareness in this area is predicted to hamper the expansion of the global metagenomics market. The development of the market is further projected to be hindered by end-user budget constraints in underdeveloped nations and the high cost of technology. Furthermore, in the forecast term, storage of sequencing data and a scarcity of experienced specialists are expected to provide challenges to the metagenomics market.

REPORT COVERAGE:

This research report on the global metagenomics market has been segmented and sub-segmented based on the product, technology, application, and region.

Metagenomics Market – By Product:

• Reagents & Consumables
• Instruments
• Services
• Analysis & Data Interpretation Solutions

Based on the product, the reagents & consumables segment dominated the global metagenomics market in 2022, and this dominance is likely to continue during the forecast period. The dominance of this segment in the market is due to the widespread use of consumables in pre-sequencing, which is one of the most critical processes in the total metagenomic sequencing protocol. Furthermore, maximizing the use of consumables guarantees that the DNA used in the metagenomic study is representative of all cells in the sample, making it suitable for the creation of genomic libraries.

Metagenomics Market – By Application:

• Infectious Disease Diagnosis
• Environmental Remediation
• Gut Microbe Characterization
• Biotechnology
• Biofuel
• Agriculture

The gut microbe characterization segment dominated the global metagenomics market in 2022, and this dominance is expected to continue over the forecast period. The human gut microbiota is a homeostatic ecosystem that has a substantial impact on human health, and disruption of this balance increases vulnerability to pathogen infections. Furthermore, metagenomics has aided in identifying bacterial pathogens such as Shiga Toxin-producing E. coli (STEC) infection, which has been linked to foodborne illness outbreaks. Therefore, the infectious illness diagnosis segment is predicted to increase at the quickest rate during the forecast period.

Metagenomics Market – By Technology:

• Sequencing Driven
• Function Driven

The segment is likely to develop as more people use function-driven metagenomics for protein screening. For example, this test can detect antibiotic resistance and vitamin synthesis. In addition, function-driven technology enables the identification of proteins implicated in pollutant degradation and the prediction of degradation rates. For example, it has been used to decipher the in-situ biodegradation mechanism of organophosphorus compounds and estimate their degradation potential.

Metagenomics Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Due to the existence of a high number of pharmaceutical and biotechnological industries striving to construct unique and efficient metagenomic platforms, as well as increased R&D investments by the leading players, North America is likely to occupy a considerable share in the global market during the forecast period. In addition, the region's market is being driven by the widespread usage of metagenomics diagnostics and an increasing number of next-generation sequencing (NGS)-based research and technological advancements. As a result, the United States had the highest share in the North American region in 2022. Furthermore, the growing elderly population and the increasing prevalence of chronic diseases are predicted to contribute significantly to the market's growth.

Europe was the world's second-largest market for metagenomics worldwide in 2021. Increased EU initiatives to transform the Research Network in Biodiversity and Evolutionary Biology (InBIO) in Portugal into a hub for top-level research in metagenomics, according to The Community Research and Development Information Service (CORDIS), constitute a significant factor boosting the market in Europe. In addition, the market in the region is projected to be driven by the use of bioinformatics tools in metagenomics analysis.

On the other hand, the Asia-Pacific area is expected to grow at the fastest rate during the projected period, owing to the region's large patient population base and constantly expanding healthcare infrastructure. China is expected to lead the metagenomics market in the APEJ region. Throughout the forecast period, Increased demand for genetic sequencing, a high prevalence of infectious disorders, and increased funding in gene research are driving the market growth.

KEY MARKET PLAYERS:

Agilent Technologies, Inc., Enterome SA, F. Hoffmann-La Roche Ltd., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN N.V., Swift Biosciences Inc. and Thermo Fisher Scientific, Inc. are some of the prominent companies operating in the global metagenomics market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• QIAGEN and Sysmex Corporation formed a strategic collaboration in 2021 to develop and commercialize global cancer companion diagnostics using NGS and Plasma-Safe-SeqS technology.
• In 2020, Illumina, Inc. announced a global strategic agreement with IDbyDNA Inc., a metagenomics technology business that defines standard for microorganism detection, identification, and interpretation and their role in human health.